AD 0261
Alternative Names: GG 1127Latest Information Update: 02 Feb 2001
At a glance
- Originator Mitsubishi Pharma Corporation
- Class Antiallergics; Antihistamines; Antipruritics
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Skin disorders
Most Recent Events
- 02 Feb 2001 Discontinued-Preclinical for Skin disorders in Japan (Topical)
- 10 Sep 1997 No-Development-Reported for Skin disorders in Japan (Topical)
- 20 Nov 1995 Preclinical development for Skin disorders in Japan (Topical)